▶ 調査レポート

PCR・リアルタイムPCR分子診断の世界市場2020-2030:技術別(従来型PCR、リアルタイムPCR、デジタルPCR)、製品別、用途別、エンドユーザー別

• 英文タイトル:PCR & Real-time PCR Molecular Diagnostics Market (Technology: Traditional PCR, Real-time PCR, and Digital PCR; Product: Instruments, Reagents, and Consumables; Application: Infectious Diseases Testing, Oncology Testing, Genetic Testing, and Others; and End User: Hospitals, Diagnostic Laboratories, Academic & Academic & Research Centers, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。PCR・リアルタイムPCR分子診断の世界市場2020-2030:技術別(従来型PCR、リアルタイムPCR、デジタルPCR)、製品別、用途別、エンドユーザー別 / PCR & Real-time PCR Molecular Diagnostics Market (Technology: Traditional PCR, Real-time PCR, and Digital PCR; Product: Instruments, Reagents, and Consumables; Application: Infectious Diseases Testing, Oncology Testing, Genetic Testing, and Others; and End User: Hospitals, Diagnostic Laboratories, Academic & Academic & Research Centers, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / D0SP201108資料のイメージです。• レポートコード:D0SP201108
• 出版社/出版日:Transparency Market Research / 2020年9月28日
• レポート形態:英文、PDF、180ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥602,680 (USD5,795)▷ お問い合わせ
  Multi User¥914,680 (USD8,795)▷ お問い合わせ
  Corporate License¥1,226,680 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査レポートでは、PCR・リアルタイムPCR分子診断の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、技術別(従来型PCR、リアルタイムPCR、デジタルPCR)分析、製品別(機器、試薬、消耗品)分析、用途別(感染症検査、腫瘍検査、遺伝子検査、その他)分析、エンドユーザー別(病院、診断研究所、学術研究センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定/調査手法
・エグゼクティブサマリー
・市場概要
・市場動向
・PCR・リアルタイムPCR分子診断の世界市場規模:技術別(従来型PCR、リアルタイムPCR、デジタルPCR)
・PCR・リアルタイムPCR分子診断の世界市場規模:製品別(機器、試薬、消耗品)
・PCR・リアルタイムPCR分子診断の世界市場規模:用途別(感染症検査、腫瘍検査、遺伝子検査、その他)
・PCR・リアルタイムPCR分子診断の世界市場規模:エンドユーザー別(病院、診断研究所、学術研究センター、その他)
・PCR・リアルタイムPCR分子診断の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

PCR & Real-time PCR Molecular Diagnostics Market – Scope of the Report

TMR’s report on the global PCR & real-time PCR molecular diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global PCR & real-time PCR molecular diagnostics market for period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global PCR & real-time PCR molecular diagnostics market for the same period.

The report has been prepared after extensive research. Primary research involves bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global PCR & real-time PCR molecular diagnostics market.

Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global PCR & real-time PCR molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global PCR & real-time PCR molecular diagnostics market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global PCR & real-time PCR molecular diagnostics market. The next section of the report highlights the USPs, which include regulatory scenario, overview of in-vitro diagnostics market, technological advancement, key industry events (mergers, acquisitions, collaborations, approvals, etc.), and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact).

The report delves into the competitive landscape of the global PCR & real-time PCR molecular diagnostics market. Key players operating in the global PCR & real-time PCR molecular diagnostics market have been identified and each one of them has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global PCR & real-time PCR molecular diagnostics market profiled in this report.

Key Questions Answered in PCR & Real-time PCR Molecular Diagnostics Market Report

What are major drivers, restraints, and opportunities in the global PCR & real-time PCR molecular diagnostics market?
What is the revenue share projection of key segments of the global PCR & real-time PCR molecular diagnostics market during the forecast period?
Which segment is likely to lead the global PCR & real-time PCR molecular diagnostics market in terms of revenue between 2020 and 2030?
How mergers & acquisitions among players are widening the scope of the global PCR & real-time PCR molecular diagnostics market?
What is the market position of different companies operating in the global PCR & real-time PCR molecular diagnostics market?
PCR & Real-time PCR Molecular Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global PCR & real-time PCR molecular diagnostics market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global PCR & real-time PCR molecular diagnostics market. It is followed by market introduction, market dynamics, and an overview of the global PCR & real-time PCR molecular diagnostics market, which includes TMR’s analysis of market drivers, restraints, and trends pertaining to the global PCR & real-time PCR molecular diagnostics market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global PCR & real-time PCR molecular diagnostics market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report segments the global PCR & real-time PCR molecular diagnostics market in terms of technology, product, application, end user, and region. Key segments under each criterion have been studied at length and the market share for each segment by the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global PCR & real-time PCR molecular diagnostics market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR & Real-time PCR Molecular Diagnostics Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast, 2018–2030

5. Market Outlook

5.1. Technology Advancement

5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.)

5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis

6. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology

6.1. Introduction & Definition

6.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

6.2.1. Traditional PCR

6.2.2. Real-time PCR

6.2.3. Digital PCR

6.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology

7. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product

7.1. Introduction & Definition

7.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

7.2.1. Instruments

7.2.2. Reagents

7.2.3. Consumables

7.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product

8. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application

8.1. Introduction & Definition

8.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

8.2.1. Infectious Diseases Testing

8.2.1.1. HCV & HBV

8.2.1.2. Sexually Transmitted Infections

8.2.1.3. Hospital Acquired Infection

8.2.1.4. Respiratory Infections

8.2.1.5. Others

8.2.2. Oncology Testing

8.2.3. Genetic Testing

8.2.4. Others

8.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application

9. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user

9.1. Introduction & Definition

9.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

9.2.1. Hospitals

9.2.2. Diagnostic Laboratories

9.2.3. Academic & Research Centers

9.2.4. Others

9.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user

10. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region

10.1. Introduction

10.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Region, 2018–2030

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Region

11. North America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

11.1. Introduction

11.2. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

11.2.1. Traditional PCR

11.2.2. Real-time PCR

11.2.3. Digital PCR

11.3. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

11.3.1. Instruments

11.3.2. Reagents

11.3.3. Consumables

11.4. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

11.4.1. Infectious Diseases Testing

11.4.1.1. HCV & HBV

11.4.1.2. Sexually Transmitted Infections

11.4.1.3. Hospital Acquired Infection

11.4.1.4. Respiratory Infections

11.4.1.5. Others

11.4.2. Oncology Testing

11.4.3. Genetic Testing

11.4.4. Others

11.5. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

11.5.1. Hospitals

11.5.2. Diagnostic Laboratories

11.5.3. Academic & Research Centers

11.6. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country, 2018–2030

11.6.1. U.S.

11.6.2. Canada

11.7. North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

11.7.1. By Technology

11.7.2. By Product

11.7.3. By Application

11.7.4. By End-user

11.7.5. By Country

12. Europe PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

12.1. Introduction

12.2. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

12.2.1. Traditional PCR

12.2.2. Real-time PCR

12.2.3. Digital PCR

12.3. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

12.3.1. Instruments

12.3.2. Reagents

12.3.3. Consumables

12.4. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

12.4.1. Infectious Diseases Testing

12.4.1.1. HCV & HBV

12.4.1.2. Sexually Transmitted Infections

12.4.1.3. Hospital Acquired Infection

12.4.1.4. Respiratory Infections

12.4.1.5. Others

12.4.2. Oncology Testing

12.4.3. Genetic Testing

12.4.4. Others

12.5. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

12.5.1. Hospitals

12.5.2. Diagnostic Laboratories

12.5.3. Academic & Research Centers

12.6. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

12.7.1. By Technology

12.7.2. By Product

12.7.3. By Application

12.7.4. By End-user

12.7.5. By Country/Sub-region

13. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

13.1. Introduction

13.2. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

13.2.1. Traditional PCR

13.2.2. Real-time PCR

13.2.3. Digital PCR

13.3. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

13.3.1. Instruments

13.3.2. Reagents

13.3.3. Consumables

13.4. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

13.4.1. Infectious Diseases Testing

13.4.1.1. HCV & HBV

13.4.1.2. Sexually Transmitted Infections

13.4.1.3. Hospital Acquired Infection

13.4.1.4. Respiratory Infections

13.4.1.5. Others

13.4.2. Oncology Testing

13.4.3. Genetic Testing

13.4.4. Others

13.5. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

13.5.1. Hospitals

13.5.2. Diagnostic Laboratories

13.5.3. Academic & Research Centers

13.6. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

13.6.1. Japan

13.6.2. China

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

13.7.1. By Technology

13.7.2. By Product

13.7.3. By Application

13.7.4. By End-user

13.7.5. By Country/Sub-region

14. Latin America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

14.1. Introduction

14.2. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

14.2.1. Traditional PCR

14.2.2. Real-time PCR

14.2.3. Digital PCR

14.3. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

14.3.1. Instruments

14.3.2. Reagents

14.3.3. Consumables

14.4. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

14.4.1. Infectious Diseases Testing

14.4.1.1. HCV & HBV

14.4.1.2. Sexually Transmitted Infections

14.4.1.3. Hospital Acquired Infection

14.4.1.4. Respiratory Infections

14.4.1.5. Others

14.4.2. Oncology Testing

14.4.3. Genetic Testing

14.4.4. Others

14.5. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

14.5.1. Hospitals

14.5.2. Diagnostic Laboratories

14.5.3. Academic & Research Centers

14.6. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

14.7.1. By Technology

14.7.2. By Product

14.7.3. By Application

14.7.4. By End-user

14.7.5. By Country/Sub-region

15. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast

15.1. Introduction

15.2. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030

15.2.1. Traditional PCR

15.2.2. Real-time PCR

15.2.3. Digital PCR

15.3. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030

15.3.1. Instruments

15.3.2. Reagents

15.3.3. Consumables

15.4. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030

15.4.1. Infectious Diseases Testing

15.4.1.1. HCV & HBV

15.4.1.2. Sexually Transmitted Infections

15.4.1.3. Hospital Acquired Infection

15.4.1.4. Respiratory Infections

15.4.1.5. Others

15.4.2. Oncology Testing

15.4.3. Genetic Testing

15.4.4. Others

15.5. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030

15.5.1. Hospitals

15.5.2. Diagnostic Laboratories

15.5.3. Academic & Research Centers

15.6. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis

15.7.1. By Technology

15.7.2. By Product

15.7.3. By Application

15.7.4. By End-user

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player – Competition Matrix (by tier and size of companies)

16.2. Global PCR & Real-time PCR Molecular Diagnostics Market Position Analysis, by Company, 2019

16.3. Company Profiles

16.3.1. Abbott Laboratories

16.3.1.1. Company Description

16.3.1.2. Business Overview

16.3.1.3. Financial Overview

16.3.1.4. Strategic Overview

16.3.1.5. SWOT Analysis

16.3.2. Elekta AB Bio-Rad Laboratories, Inc.

16.3.2.1. Company Description

16.3.2.2. Business Overview

16.3.2.3. Financial Overview

16.3.2.4. Strategic Overview

16.3.2.5. SWOT Analysis

16.3.3. bioMérieux SA

16.3.3.1. Company Description

16.3.3.2. Business Overview

16.3.3.3. Financial Overview

16.3.3.4. Strategic Overview

16.3.3.5. SWOT Analysis

16.3.4. Danaher Corporation

16.3.4.1. Company Description

16.3.4.2. Business Overview

16.3.4.3. Strategic Overview

16.3.4.4. Financial Overview

16.3.4.5. SWOT Analysis

16.3.5. Thermo Fisher Scientific, Inc.

16.3.5.1. Company Description

16.3.5.2. Business Overview

16.3.5.3. Strategic Overview

16.3.5.4. Financial Overview

16.3.5.5. SWOT Analysis

16.3.6. Becton, Dickinson and Company

16.3.6.1. Company Description

16.3.6.2. Business Overview

16.3.6.3. Strategic Overview

16.3.6.4. Financial Overview

16.3.6.5. SWOT Analysis

16.3.7. F. Hoffmann-La Roche Ltd

16.3.7.1. Company Description

16.3.7.2. Business Overview

16.3.7.3. Strategic Overview

16.3.7.4. Financial Overview

16.3.7.5. SWOT Analysis

16.3.8. QIAGEN N.V.

16.3.8.1. Company Description

16.3.8.2. Business Overview

16.3.8.3. Strategic Overview

16.3.8.4. Financial Overview

16.3.8.5. SWOT Analysis

16.3.9. Hologic, Inc.

16.3.9.1. Company Description

16.3.9.2. Business Overview

16.3.9.3. Strategic Overview

16.3.9.4. Financial Overview

16.3.9.5. SWOT Analysis

16.3.10. GRIFOLS, S.A.

16.3.10.1. Company Description

16.3.10.2. Business Overview

16.3.10.3. Strategic Overview

16.3.10.4. Financial Overview

16.3.10.5. SWOT Analysis

16.3.11. Genomic Health

16.3.11.1. Company Description

16.3.11.2. Business Overview

16.3.11.3. Strategic Overview

16.3.11.4. Financial Overview

16.3.11.5. SWOT Analysis

16.3.12. Seegene, Inc.

16.3.12.1. Company Description

16.3.12.2. Business Overview

16.3.12.3. Strategic Overview

16.3.12.4. Financial Overview

16.3.12.5. SWOT Analysis

List of Tables

Table 01 Global In-vitro Diganostics (IVD) Market for Infectious Disease, Oncology, Genetics Market Value Analysis and Forecast, 2018–2030

Table 02 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 03 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 04 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 05 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 06 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 07 Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 08 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 09 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 10 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 11 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 12 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 13 North America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 14 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 15 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 16 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 17 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 18 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 19 Europe PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 20 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 22 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 23 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 24 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 25 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 26 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 28 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 29 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 30 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 31 Latin America PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 32 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 33 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030

Table 34 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 35 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 36 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030

Table 37 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030